About Index Trending news
Analyze
Top 50 Pricing
Immunomic Therapeutics

Immunomic Therapeutics

Work at Immunomic Therapeutics? Add yourself to this profile

Immunomic Therapeutics

Bill is CEO of Immunomic Therapeutics, a biotech company pioneering next generation vaccines that will transform lives.

Elsewhere

Alexa global traffic share

Twitter followers

Latest funding Show all
Venture capital
$1,028,999
Venture capital
$3,000,000
Employees

Unknown size

Technical.ly

Immunomic Therapeutics is launching an incubator and looking for one lucky startup Baltimore

Funding Education